BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26008822)

  • 1. Nrf2 inducer and cncC overexpression attenuates neurodegeneration due to α-synuclein in Drosophila.
    Wang B; Liu Q; Shan H; Xia C; Liu Z
    Biochem Cell Biol; 2015 Aug; 93(4):351-8. PubMed ID: 26008822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Nrf2 in Astrocytes Suppressed PD-Like Phenotypes via Antioxidant and Autophagy Pathways in Rat and Drosophila Models.
    Guo Q; Wang B; Wang X; Smith WW; Zhu Y; Liu Z
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.
    Barone MC; Sykiotis GP; Bohmann D
    Dis Model Mech; 2011 Sep; 4(5):701-7. PubMed ID: 21719443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
    Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegenerative phenotypes in an A53T α-synuclein transgenic mouse model are independent of LRRK2.
    Daher JP; Pletnikova O; Biskup S; Musso A; Gellhaar S; Galter D; Troncoso JC; Lee MK; Dawson TM; Dawson VL; Moore DJ
    Hum Mol Genet; 2012 Jun; 21(11):2420-31. PubMed ID: 22357653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A53T Mutant Alpha-Synuclein Induces Tau-Dependent Postsynaptic Impairment Independently of Neurodegenerative Changes.
    Teravskis PJ; Covelo A; Miller EC; Singh B; Martell-Martínez HA; Benneyworth MA; Gallardo C; Oxnard BR; Araque A; Lee MK; Liao D
    J Neurosci; 2018 Nov; 38(45):9754-9767. PubMed ID: 30249789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila.
    Zhu ZJ; Wu KC; Yung WH; Qian ZM; Ke Y
    Biochim Biophys Acta; 2016 Apr; 1862(4):518-525. PubMed ID: 26769358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
    Smith WW; Jiang H; Pei Z; Tanaka Y; Morita H; Sawa A; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 2005 Dec; 14(24):3801-11. PubMed ID: 16239241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model.
    Gan L; Vargas MR; Johnson DA; Johnson JA
    J Neurosci; 2012 Dec; 32(49):17775-87. PubMed ID: 23223297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism.
    Liu Z; Yu Y; Li X; Ross CA; Smith WW
    Pharmacol Res; 2011 May; 63(5):439-44. PubMed ID: 21237271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.
    M'Angale PG; Staveley BE
    BMC Neurosci; 2016 May; 17(1):24. PubMed ID: 27192974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
    Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
    Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease.
    Botella JA; Bayersdorfer F; Schneuwly S
    Neurobiol Dis; 2008 Apr; 30(1):65-73. PubMed ID: 18243716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the
    Golomidov IM; Latypova EM; Ryabova EV; Bolshakova OI; Komissarov AE; Sarantseva SV
    J Neurogenet; 2022 Mar; 36(1):1-10. PubMed ID: 35467466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of neuromotor deficits by natural antioxidants of Decalepis hamiltonii in transgenic Drosophila model of Parkinson's disease.
    Jahromi SR; Haddadi M; Shivanandappa T; Ramesh SR
    Neuroscience; 2015 May; 293():136-50. PubMed ID: 25754960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.
    Lastres-Becker I; Ulusoy A; Innamorato NG; Sahin G; Rábano A; Kirik D; Cuadrado A
    Hum Mol Genet; 2012 Jul; 21(14):3173-92. PubMed ID: 22513881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein.
    Dhanushkodi NR; Abul Khair SB; Ardah MT; Haque ME
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant alpha-synuclein-induced degeneration is reduced by parkin in a fly model of Parkinson's disease.
    Haywood AF; Staveley BE
    Genome; 2006 May; 49(5):505-10. PubMed ID: 16767175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
    Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
    PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.